Article

Florida Cancer Specialists, Cigna Expand Collaboration to All Cancer Types

Author(s):

A 28% reduction in hospital admissions leads to a broader agreement, the physicians' group and payer say.

Florida Cancer Specialists and Research Initiative (FCS) and the insurer Cigna are expanding their collaboration for value-based cancer care. Since 2015, FCS has provided services to Cigna patients through a collaborative care arrangement that included extra support, education, and efforts to reduce hospitalization and unnecessary visits to the emergency department.

Those efforts were initially offered to patients with breast, lung, and colorectal cancers, leukemia, and lymphoma and resulted in a 28% lower inpatient admission rate compared with patients outside the value-based model. So now, the collaboration will involve patients with all cancer diagnoses and provide additional treatment therapies.

For more, see the full press release here.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Erin Weber, MS
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Erin Weber, MS
Andrew Kuykendall, MD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
AMCP Recap 2025
Andrew Evens, DO
Screenshot from interview with Andrew Evens, DO
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo